United States · Investor

Washington Research Foundation

Last cheque observed Nov 2025; 38 cheques on record.

Deploying nowVC firmWebsite unconfirmed

SeedSeries ASeries BSemi-conductorSmartphoneQuantum Computing

Deploying now
100%of best year1cheques in 12 months, 38 on record
Since the last cheque354days00hrs00min00sec
Median round$3.0MRounds led0 of 38Exits4 from the portfolioMostly inUnited States, 100%
Pitch Washington Research Foundation

Washington Research Foundation highlights

  1. 01

    1 cheques in the last 12 months

  2. 02

    Mostly Series B and Series A: 66% of its rounds

  3. 03

    4 exits from the portfolio

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
Semi-conductorSmartphoneQuantum Computing
Based in
Seattle, United States
Cold pitches
Not stated

A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.

The record

Every round we can evidence, newest first38 appearances

  1. 2025

    1 round

  2. Nov
    Accipiter BiosciencesSeed · US · Columbus Venture Partners$13MWith 8 others
  3. 2019

    2 rounds

  4. Sept
    A-Alpha BioUS · FinSMEs$2.8MWith 5 others
  5. May
    MDMetrixUS · GeekWire$3.0MWith 2 others
  6. 2015

    2 rounds

  7. Sept
    AnswerDashSeed · US$2.9MWith 4 others
  8. May
    CSATSVenture · US$2.5MWith 3 others
  9. 2014

    2 rounds

  10. Mar
    FlexMinderSeries A · US$1.2MWith 3 others
  11. Feb
    SkytapSeries C · US$6.5MWith 3 others
  12. 2013

    2 rounds

  13. Dec
    QazzowSeries A · US$2.4MWith 4 others
  14. Jan
    FlexMinderSeries A · US · freshnews.com$1.4MWith 3 others
  15. 2012

    3 rounds

  16. Nov
    Resolve TherapeuticsSeries B · US · finsmes.com$5.8MWith 2 others
  17. Apr
    Alder BiopharmaceuticalsSeries D · US · prnewswire.com$38MWith 6 others
  18. Mar
    Uptake MedicalSeries C · US · sec.gov$40MWith 6 others
  19. 2011

    4 rounds

  20. Dec
    Groove BiopharmaSeries B · US · finsmes.com$6.0MWith 3 others
  21. Aug
    Oncofactor CorporationSeries A · US · onbiovc.com$2.1MWith 5 others
  22. Jul
    Mirador BiomedicalSeries B · US · onbiovc.com$1.5MWith 2 others
  23. Jun
    NimbicSeries B · US · nimbic.com$6.9MWith 2 others
  24. 2010

    2 rounds

  25. Jul
    Uptake MedicalSeries B · US · uptakemedical.com$18MWith 5 others
  26. Apr
    Groove BiopharmaSeries A · US · xconomy.com$3.9MWith 4 others
  27. 2009

    3 rounds

  28. Mar
    SkytapSeries B · US · techflash.com$7.0MWith 2 others
  29. Feb
    ArzedaSeries A · US · biospace.com$12MWith 1 other
  30. Jan
    CorensicSeries A · US$1.5MWith 2 others
  31. 2008

    1 round

  32. Feb
    NimbicSeries A · US · siliconindia.com$2.5MWith 1 other
  33. 2007

    8 rounds

  34. Sept
    GlobeImmuneSeries C · US$41MWith 5 others
  35. Sept
    Hyperion TherapeuticsSeries B · US · deals.venturebeat.com$40MWith 3 others
  36. Aug
    Accelerator Corp.Series C · US$23MWith 4 others
  37. Aug
    SkytapSeries A · US · seattletimes.nwsource.com$6.0MWith 3 others
  38. Mar
    HaloSourceVenture · US$6.0MWith 2 others
  39. Feb
    OmerosSeries E · US · investor.omeros.com$63MWith 7 others
  40. Feb
    Targeted GrowthSeries D · US · redherring.com$22MWith 4 others
  41. Jan
    FarecastSeries C · US · farecast.com$12MWith 5 others
  42. 2006

    3 rounds

  43. Jul
    Alder BiopharmaceuticalsSeries B · US$16MWith 3 others
  44. Jun
    VLST CorporationSeries B · US · vlstcorp.com$55MWith 6 others
  45. May
    Targeted GrowthSeries D · US$10MWith 3 others
  46. 2005

    4 rounds

  47. Sept
    TeranodeSeries B · US · biospace.com$9.5MWith 3 others
  48. Jul
    Alder BiopharmaceuticalsSeries A · US$11MWith 2 others
  49. Jul
    FarecastSeries B · US · farecast.com$7.0MWith 2 others
  50. Mar
    Vanson HaloSourceSeries B · US$5.0MWith 3 others
  51. 2004

    1 round

  52. Oct
    FarecastSeries A · US · farecast.com$1.5MWith 1 other

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 4 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed4 in all

Hyperion TherapeuticsBought by Horizon Pharma$1.1BMar 2015
NimbicBought by Mentor GraphicsUndisclosedMay 2014
OmerosListedUndisclosedOct 2009
FarecastBought by Microsoft$115MApr 2008

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as Washington Research Foundation. A count of rooms they were both in, not a relationship either has claimed.

Madrona Venture GroupVC firm10rounds togetherARCH Venture PartnersVC firm6rounds togetherOVP Venture PartnersVC firm6rounds togetherIgnition PartnersVC firm4rounds togetherAlexandria Real Estate EquitiesVC firm3rounds togetherAlliance of AngelsAngel network3rounds togetherFounders' Co-opVC firm3rounds togetherSevin Rosen FundsVC firm3rounds togetherSummit CapitalFamily office3rounds togetherThe W FundVC firm3rounds togetherVentures WestVC firm3rounds togetherAffinity Capital ManagementVC firm2rounds together

Recently backed

The latest companies Washington Research Foundation put money into.

Accipiter Biosciences$13M · Nov 2025A-Alpha Bio$2.8M · Sept 2019

Quick answers about Washington Research Foundation

What does Washington Research Foundation invest in?

Washington Research Foundation invests most often at Series B and Series A (66% of the rounds on record), in sectors such as Semi-conductor, Smartphone and Quantum Computing.

How active is Washington Research Foundation?

38 investments on record, 1 of them in the last 12 months. The most recent was in Nov 2025.

What has Washington Research Foundation invested in recently?

Its most recent investments on record: Accipiter Biosciences (Seed, Nov 2025), A-Alpha Bio (Undisclosed round, Sept 2019) and MDMetrix (Undisclosed round, May 2019).

How big are Washington Research Foundation's cheques?

The median round it joins is $3.0M.

Does Washington Research Foundation lead rounds?

Rarely, if at all: none of its 38 investments on record names it as the lead.

Where does Washington Research Foundation invest?

Most of the companies it backs are in the United States (100%).

Is Washington Research Foundation investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

Who does Washington Research Foundation invest alongside?

Most often Madrona Venture Group (10 rounds together), ARCH Venture Partners (6 rounds together) and OVP Venture Partners (6 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it